Even a U-Turn on planned cuts to the service itself will still leave the NHS under heavy pressure.
Can drugs help depression? Crowdfunding allows science researchers to bypass institutional reservations and study taboo subjects.
Often beyond the realms of common sense, vitamins have become the most effective sales tool in food marketing.
This month, researchers are gathering in Cambridge to try and work out why we hurt. Michael Brooks weighs up one suggestion.
In this week's Health Matters, a man finds he has been hurt on the way home - and Phil Whitaker suggests sometimes the best thing to do is move on.
How will we create the UK's first dementia-friendly generation, and why do we need to?
It's hard to draw the line between inciting fear, and giving a fair warning - as Colin and Mary's story proves.
Successive attempts by Labour and the Tories to update the service have done more bad than good. It's time to put the NHS in intensive care.
Oliver Sacks wrote of his imminent death with remarkable dignity, knowing science cannot help him. But what about the cases where it might?
Meet the co-founder of New Yorkers Against Bratton, who wants New York cops to clean up their act.
Hundreds of man hours lost to the economy, and a severe failure when it comes to cancer patients. It's time for NHS reform.
We notice you have ad blocking software enabled. Support the New Statesman’s quality, independent journalism by contributing now — and this message will disappear for the next 30 days.
If we cannot support the site on advertising revenue, we will have to introduce a pay wall — meaning fewer readers will have access to our incisive analysis, comprehensive culture coverage and groundbreaking long reads.